Evaluation of the STOP-BANG Screening Questionnaire in a Sleep Clinic

Obstructive Sleep Apnea Clinical Trial

Official title:

Evaluation of the STOP-BANG Screening Questionnaire in a Sleep Clinic

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02293421
• Other study ID #: OSA STOP-BANG
• Status: Completed
• Phase: N/A
• First received: November 13, 2014
• Last updated: December 17, 2017
• Start date: November 2014
• Est. completion date: October 1, 2017

Study information

• Verified date: December 2017
• Source: Karolinska University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Although obstructive sleep apnea (OSA) is common, most of the patients are undiagnosed. OSA is associated with a large number of co-morbidities, and thus, it is of great importance to identify the patients and start treatment in order to reduce the risks for complications. Current screening tools are quite unspecific and the golden standard methodology for diagnosis, polysomnography, is expensive and time consuming, thus not suitable for screening. In perioperative medicine the STOP BANG screening questionnaire is currently the recomended screening tool, however this questionnaire has only been evaluated in a sleep clinic in a very limited numbers of patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 449
• Est. completion date: October 1, 2017
• Est. primary completion date: February 1, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• More than 18 years old

• First or part of the first visit to a sleep clinic

• Planned or just conducted polysomography

Exclusion Criteria:

• Not able to understand the information and sign informed consent

Related Conditions & MeSH terms

• Obstructive Sleep Apnea
• Sleep Apnea, Obstructive

Intervention

Other:
• Obstructive sleep apnea

Locations

Country	Name	City	State
Sweden	Department of Anesthesiology, Surgical Sciences and Intensive Care Medicine, Karolinska University Hospital, Solna	Stockholm

Sponsors (5)

Lead Sponsor	Collaborator
Karolinska University Hospital	Stockholm Heart Center, Sweden, Sunderbyn Hospital, Umeå University, Uppsala University Hospital

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	STOP BANG		At diagnosis, one time
Primary	Snore question		At diagnosis, one time
Primary	Polygraphy	Apnea hypopnea index (AHI, oxygen desatuaration index (ODI)	At diganosis, one time
Secondary	Pulseoximetry		At dignosis, one time